Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Q1 2024 vs. Q4 2023
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 25 | 31 | +6 |
| Shares | 1.90M | 2.72M | +821.7K (+43.2%) |
| Value | $2.83M | $1.53M | −$1.29M (−45.7%) |
New holders (9)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apollo Management Holdings, L.P. | 125,000 | $70.6K | 0.00% |
| CPR Investments Inc. | 70,000 | $44.8K | 0.03% |
| Evermay Wealth Management LLC | 63,416 | $35.8K | 0.01% |
| Marshall Wace, LLP | 61,869 | $35.3K | 0.00% |
| 683 Capital Management, LLC | 48,016 | $27.1K | 0.00% |
| Virtu Financial LLC | 42,062 | $24.0K | 0.00% |
| RS Crum Inc. | 10,854 | $6.13K | 0.00% |
| Creative Planning | 10,000 | $5.65K | 0.00% |
| Advisor Group Holdings, Inc. | 2,525 | $1.44K | 0.00% |
Sold out (3)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Millennium Management LLC | 102,317 | $154.5K |
| Renaissance Technologies LLC | 17,079 | $26.0K |
| Axxcess Wealth Management, LLC | 13,190 | $19.9K |